Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry to hear, it’s unhealthy and somehow silly to continue to work for RVNC in your circumstances
Are you good at what you do?
If you are, just quit and move on. If not, maybe just accept the facts that sometimes somehow some even more incompetent people will become your leader.
Life is too short to be living so miserablely.
Not trying to be offensive here but sometimes, you have to learn to let go
I'm sorry you lost money on the stock and are concerned about your job security. I am in the camp that Foley is a disaster and should be exited. However, your claim about social media is wrong. The majority of social media posts shared here are not from Revance but actually from Revance's customers. Many people here have first-hand experience with Daxxify. To suggest that is all just marketing is completely disingenuous.
This is the most considerate post I’ve read here.
As a current Revance employee it’s been hard to read many statements here not based in reality, a truth that those of us who are living it daily know.
More difficult are comments here about my colleagues losing their jobs as “cutting the fat” or “losers in marketing” or worse “good riddance”, as if applauding the indescribable loss of livelihoods and many millions in employee stock grants and purchases that have disappeared overnight.
We are not “savvy investors”, and a lot of us have never sold a single share of Revance stock. We are humans first, and employees with kids, babies on the way, student loan debt, mortgages, retirement plans. Our compensation packages were initially structured where Revance stock was big financial motivator to stay. We also believe(d) in the product but not in Dustin and Mark’s strategy, yes Mark was in on it. It was a strategy I quietly questioned.
When stock began to fall employees were on long black out periods and could not sell, so we were offered revised comp packages with more stock incentives to keep us working tirelessly to support a marketing strategy most of us didn’t believe in.
Our executive leaders have been kept in the dark and axed too with no notice. Our CEO has yet to hold a town hall, nor has he sent a company-wide email of encouragement. There is a complete lack of transparency or compassion in the rest of the C-suite.
When this forum is encouraged by Revance social media posts and Erica posing in front of a Power to the Peptide wrapped car I shared they shouldn’t be, it’s straight up advertising. It’s not that I hate Revance and Daxxify or want it to fail, quite the opposite, my attempt here was to provide information that could curb false speculation. More to the point my posts were meant to say, if you are basing financial decisions on Revance social media posts, please don’t.
To date I have lost almost $400k in Revance stock, I imagine some of my colleagues with bigger titles or longer stints have lost a lot more, but that’s a life changing amount of money for me.
Working at Revance is as Emmanow said, “sad”. It’s also like walking barefoot on a tight rope laden with shards of glass. We don’t sleep at night with worry, by day it’s hard to focus on work. Any day now I’ll get an HR meeting added to my calendar late at night and at 8 am I’ll log on from home for a 2 minute conversation to inform me I’m another Revance casualty with a 2 month severance. At the end of that call my laptop will instantly lock and the Revance waking nightmare I’ve been living will end.
Thank you Emmanow for showing some real compassion here. 🙂
If they sold anywhere close to 8, that could only mean they have been lying about blockbuster potential of Daxxify all along.
No one would sell a potential blockbuster drug for 1 billion EV
I do wish they would establish a commercial partnership, let a larger corporation spent tons of sales and marketing, and RVNC just collect royalties.
The same WS you mentioned paid close to 40 bucks to buy RVNC not long ago, the same WS were buying up GME and AMC into unbelievable valuations.
I bet not many in the actual wall street knows about RVNC, its a small cap for them, most of them can’t even build a decent size position without move up or down the stock substantially.
The job cut is sad but that’s probably better for everybody in the long run.
Spoke to a few people who still have jobs at RVNC Headquarters and they said it is a sad place since so many people have lost their jobs. I believe Dew's statement that Foley will eventually bring RVNC into profitability and sell the company. The sad part is Foley's bad decisions are the reason so many have lost their jobs. Foley should be ashamed of how his bad decisions negatively affected so many lives. Maybe Evolus will publish a pre release of their sales prior to Allergan's sales at the end of this month. I would expect RVNC sales to be similar to Evolus.
Per Q1 Daxi sales, I have heard several reps hit their Daxi quota ahead of their RHA quota...so Daxi is gaining traction and sales are growing. I believe Foley has a good idea on what CD sales will be and has factored these numbers into his current expenses to create a balanced spending budget for the next few quarters. RVNC will never go bankrupt since there are a hand full of companies who would buy RVNC today. Once the Allergan lawsuit is closed at the end of 2024, you will start to see buyout offers. Remember, Allergan sues everyone....There are always lawsuits happening between Allergan and their employees over miss use of the cash pay products...Allergan settles these out of court because Allergan does not want the legal system or FDA to have documented evidence of their doings. .Allergan has very dirty hands.
The sad reality is that the Wall Street computers are continuing to drive the SP down. At some point the SP will bottom which i think will be soon, Foley has to start communicating with Wall Street so investors believe in RVNC.
Those are mostly old now. Would hate to see RVNCQ tag your post with a clown emoji.
So, here's some recent ones, although these results must all be fake because I heard from CosmeticMD that Daxxify "doesn't work."
https://www.instagram.com/p/C5oQLI5yXl8/?igsh=MTduMW40bGZjbDJvZg==
https://www.instagram.com/p/C5ogTVxxGO-/?igsh=MXNudWo1Ymc0b2djMA==
https://www.instagram.com/p/C5nz-JiuvU3/?igsh=ano1cnlzb3dlNTZh
https://www.instagram.com/p/C5g4SKdxt-q/?igsh=MTRrbHR5aHR1ZXVwcg==
https://www.instagram.com/p/C5OUsswRhuQ/?igsh=NTljaW5yYnp0cWds
https://www.instagram.com/p/C48GCY9JfzA/?igsh=azZ3a3o0djRuZWZo
https://www.instagram.com/p/C44H71vx9tA/?igsh=MW43aWhnMmo1ZWIxag==
Why I’m not concerned about daxxify’s potential in the marketplace…
https://www.instagram.com/reel/C4J8jhcuIdq/?igsh=M3R2dmNrb2Vnazlx
https://www.instagram.com/reel/CiaBtY-POUg/?igsh=bzk3MXViemxqa2Vy
https://www.instagram.com/reel/C2id52jJlcG/?igsh=eXIyMDJpOXNncDh6
https://www.instagram.com/reel/CooGVafrqe_/?igsh=d2F0cDBmNXF2amVz
https://www.instagram.com/reel/CobKg6pMVWM/?igsh=NWRubTRpYzV4OHUw
Daxxify… What have we learned?
https://www.instagram.com/reel/CthjfONu9pb/?igsh=MWE3dndzbjMxcTB1bA==
Be Patient. My friends. If you know, you know.
Is there any way for a patient to determine whether or not her injector was untrained, improperly trained, or inadequately trained?
In my opinion, it’s more likely that she will blame the result on Daxxify. … loudly and vociferously to many others.
Unless, and until, RVNC corrects the training problem, selling Daxxify will be an uphill battle
I suspect between likely no rate cuts this year, a difficult balance sheet, a week Q1, and distrust of Foley, we will see RVNC in the $2's this year. Revance is priced for likely bankruptcy. They're hardly alone. Nobody wants to own unprofitable small caps with debt in this environment. Many of these companies will go bankrupt. If Revance doesn't then we will likely look back on the current share price as an excellent opportunity. The RVNCQ clowns on this board want to convince everyone that the share price collapse is proof Daxxify "doesn't work" or is inferior to other toxins. That's wrong.
Her reply to my follow up:
Oh, it’s really good. I haven’t even thought of it since it’s lasted longer than usual.
As succinct a rave as I could wish for.
I’ll throw a personal review in the mix, this is from my mother, late 60s, long time user of Botox and most recently Dysport. Her injector is a board certified MD in a major US city. She texted this before her appointment.
—
Dr K says it is faster acting than dysport and she’s used it on herself. She sees results in a day or so. She says her patients have tolerated it well and she likes the peptides since they promote collagen growth. She is all about using the best technology and she is brilliant.
—
She got it plus filler on face (not sure of specifics) and off label for migraines and on the neck for loose skin/vertical wrinkles. She was very happy with onset and results. This was back in November so I’ll have to circle back for her thoughts and share them too.
Low skill injectors like the ones hired by CosmeticMD will deliver low quality results. That's not a problem with the product. Many powerful tools require skill to use to their full potential. In due course patients will gravitate towards the injectors with the skill to deliver the best results with the best product.
=========================
Everyone who is posting on this board, should get first-hand experience of Daxxify like Dew. Or at a minimum, purchase Daxxify for a spouse / significant other / close friend, and get a real-life experience thru them.
==============================
Wonderful rule!!!
If everybody were to follow it, including you, of course, there would only be one or two posts in the last few months.
Nobody would’ve had to have looked at yours neither.
Yep, an absolutely wonderful rule.
I don't think Ian from Stupid Island is financially compensated to shitpost about Revance and Daxxify like known liar/loser CosmeticMD is. Ian is just either really dumb or short the stock in which case he should probably cover soon.
What you depict is the polar opposite of my unbeatable first-hand experience with Daxxify (#msg-173870537).
I did. Soma’s network sees uptick in sales so its not just one clinic. Do you own a clinic too and yours is not seeing any upticks?
It's tough to be long. Few weeks ago, this was trading at $7.5.. .now almost dropped half... no new news.
Good news is we are closer to bottom whatever that is.
=======================
… having shorter acting toxins might draw people into trying toxins who normally wouldn't. If they like it they might decide to try longer lasting toxins so that could increase the market for Daxxify.
=================================
I agree that they might be drawn into a longer acting toxin that actually works for the full 6 months rather than starting to rapidly deteriorate long before the six month period is over. I doubt anyone, male or female, would be drawn to Daxxify as long as it works for two or three months and then makes you look as if you are ageing rapidly for the next three or four months.
It has been broadcast and advertised as doing wonders for six months? With that misleading BS, I doubt that it can ever be successful.
You may want to read Soma’s post one more time. He/she was referring to his/her own practice, not to the industry in general.
Soma may be able to explain why his practice is doing better than what he’s seeing in the industry, if he wishes.
==========================
"Be fearful when others are greedy, and greedy when others are fearful," said Warren Buffett, a phrase that encapsulates the contrarian philosophy.
===================================
Wow!!!
I have never seen an accurate quote so poorly used ever. In the 1st place Buffet would never touch a poorly managed company. If the managers weren’t outstanding, he would have nothing whatsoever to do with that company.
He wouldn’t even touch technology leaders. Charlie Munger did and contributed to Berkshire Hathaway success.
He clearly would not have touched an emerging biotech that had never shown a wood, nickel worth of profit, and that Wall Street had abandoned, and even the rabid speculators cursed the ineffective management every chance they got.
Good luck with your speculation. There is no way that this can still be called an investment.
The valuation is getting a bit absurd… $300M+ cash vs $430M market cap. In theory china approval can come anytime starting next week and then you have catalysts ER and therapeutics launch. If Soma is credible and Daxi is gaining traction then plenty to look forward to.
Recommend you stop buying! The shorts are going to drive the price into the "2" since FOLEY has his head up Russell's butt and he is not providing any positive guidance to create investor confidence! Yesterday, Shorts made up 57% of the trades, and today will be 60% to 70%...
Shorts are driving...This is what happens when someone who does not know what they are doing is the CEO.
Added this morning. 😊
Taking a WB approach. This will take some time to play out. And the old adage, patience is a virtue.
Contrarian investing is a strategy of going against prevailing market trends or sentiment.
The idea is that markets are subject to herding behavior augmented by fear and greed, making markets periodically over- and under-priced.
"Be fearful when others are greedy, and greedy when others are fearful," said Warren Buffett, a phrase that encapsulates the contrarian philosophy.
Historically, market panics can be a great chance for low-priced investments.
Being a contrarian can be rewarding, but it is often a risky strategy that may take a long period of time to pay off.
As well as Short acting toxins.
This is a good review after 9 months
Could they sell the company today for $8? Asking for a colleague..
Galderma, AbbVie/Allergan and Merz are all working on long and short acting toxins.
China approvals are expected for april '24 and juli '24, is stated in the 10-K
Is any company developing a ‘2nd generation’ or novel neuromodulator with similar attributes / strengths to Daxxify?
What is the likely outcome of the Allergan lawsuit and when can we expect closure on this?
I read where it takes 1-2 years for drug approvals in China 🇨🇳, so we may not see milestone payments till 2025. Opinions?
You can’t tout off-label use of a product.
I see your point and I feel your frustration. I am a significant share owner so I feel your pain. However, I am seeing Daxxify gaining significant traction in my practice and across my industry contacts. This supports my belief that the company has done enough to course correct and that patient investors will be rewarded sooner rather than later. I don't pay much attention to the first 12 months of a commercial launch. The numbers that will matter most to me is Q2 2024 vs Q2 2023 year over year growth comps and each quarter after that out to mid 2025. Over 10 years of drug development and $1B spent and I suspect we are a 18 to 24 months away from knowing if this will be a blockbuster drug for Revance.
Best product, worst stock. This won't last.
Now it is time for Revance to reignite the fire under this product and leta get back to low 30s…
Daxxify… What have we learned?
https://www.instagram.com/reel/CthjfONu9pb/?igsh=MWE3dndzbjMxcTB1bA==
I understand and respect your position and thoughts!
My issue is Foley was 100% in charge and owns the premium price strategy and also owns the fact that he waisted $300 million plus! He is the captain who has kicked everyone else off the boat he was driving and blames everyone else! He has never been a real leader and taken ownership!
I have watched all his videos and messages! Secondly, if you follow Mertz, Allergan or Evolus, their teams communicate weekly through Instagram and LinkedIn commentary on advancements with products and industry support! Foley or his team (which he may have fired everyone) has not provided a positive communication to investors or the general public since he did the last investor interview. All he discussed is how he is fixing the company..not his mistakes. He could announce the new lip indication for RHA3, he could announce their new VP of Sales who is doing…….to build and grow the RVNC culture, he could announce Dr Leed and all the Daxi trainers who are available to assist all and any practices with training and learning, he could announced the support RVNC is provided to the Nashville community, he could announce the learning and feedback from the CD Prev program, he could announce the CD sales team progress and programs, he could announce how RVNC is handling early orders for CD and off label therapeutic Daxi….there are tons of communications which could be shared which would build investor confidence and injector confidence and interest! If you know Instagram, providing quality weekly messages is #1 for development of loyal followers!
Foley seems to have this EGO and wants to surprise investors, especially the shorts, with good news rather than put out a constant flow of communications to build trust! Foley only has 1 product to make and sell Daxi and RHA to sell! Foley must communicate to investors, otherwise the shorts will continue to kill the SP! Sales are the magic, and sales grow faster when watered with positive feedback and industry news! As you know, most doctors/injectors are influenced by their doctor friends!
Foley should have a team of consultants who work with each RM and teach their practices how to schedule, price, market Daxi to their patients and the additional profit Daxi will bring rather than continuing to pay himself more! Each converted Botox to Daxi patient is worth at least $500 more profit per year to the practice! Could be $1,000. Foley does not understand the toxin industry and how to communicate!
Sorry, this got a little long 🙄🙄
Followers
|
150
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
7221
|
Created
|
02/09/14
|
Type
|
Free
|
Moderators DewDiligence |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |